FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2973044718> ?p ?o ?g. }

• W2973044718 endingPage "E204" @default.
• W2973044718 startingPage "E203" @default.
• W2973044718 abstract "To retrospectively assess the clinical characteristics, short-term efficacy, and side effects of newly diagnosed stage IVB thoracic esophageal squamous cell carcinoma (ESCC). 199 patients with stage ⅣB (according to UICC / AJCC 8th edition) newly diagnosed thoracic ESCC, which had been treated in the fourth hospital of Hebei medical university between January 2010 to December 2016, were retrospectively investigated. The difference of TNM classification between Japanese Esophagus Society (JES) 11th edition and UICC/AJCC 8th edition in predicting the prognosis of patients with advanced ESCC. Short-term efficacy: The objective response rate of primary lesion (pORR) was 82.4%. Univariate analysis showed that the tumor location (χ2=7.882，P=0.019) and treatment modalities (χ2=24.218, P =0.000) were the main factors for pORR. The pORR of upper thoracic esophagus was significantly higher than that of middle and lower thoracic esophagus (χ2=7.846, P =0.005; χ2=6.236, P =0.013). The pORR of chemotherapy group, radiotherapy group, and radiochemotherapy group were 37.5%, 86.0%, and 86.5%, respectively. The improvement rate of dysphagia (DIR) was 77.2%. Univariate analysis showed that the type of metastasis (χ2=13.513, P=0.001) and treatment modalities (χ2=13.790, P=0.001) were the main factors for DIR. The DIR of distant lymph node metastasis only was significantly higher than that of solid organ metastasis only (χ2=12.812, P =0.000). The DIR of chemotherapy alone , radiotherapy alone and radiochemotherapy were 30.0%, 77.5%, and 81.5%, respectively. The median OS (mOS) of the entire cohort was 14.0 months (95% CI: 11.826-16.174m), and the survival rates for 1 year, 3 years, and 5 years were 53.2%, 15.8%, and 10.7%, respectively. Multivariate analysis showed that tumor length, the number of metastatic organs, and chemotherapy were independent prognostic factors for OS. According to TNM classification of esophageal cancer of JES 11th edition, there was no significant difference for OS between stage Ⅲ and stage Ⅳ(χ2=0.521, P=0.470). For metastatic esophageal cancer, compared with chemotherapy and radiotherapy alone, radiotherapy combined with chemotherapy could obtain good local control, improve dysphagia and might prolong survival. For patients with good performance status, radiotherapy could be considered on the basis of systemic chemotherapy to participate in the comprehensive treatment of stage Ⅳ esophageal cancer as far as possible, and individualized choice of sequential or simultaneous radiotherapy and chemotherapy mode." @default.
• W2973044718 created "2019-09-19" @default.
• W2973044718 creator A5017951736 @default.
• W2973044718 creator A5051744400 @default.
• W2973044718 creator A5080071712 @default.
• W2973044718 date "2019-09-01" @default.
• W2973044718 modified "2023-09-23" @default.
• W2973044718 title "Prognostic Analysis and Treatment Model of Newly Diagnosed Patients with Stage IVB Thoracic Esophageal Squamous Cell Carcinoma" @default.
• W2973044718 doi "https://doi.org/10.1016/j.ijrobp.2019.06.2034" @default.
• W2973044718 hasPublicationYear "2019" @default.
• W2973044718 type Work @default.
• W2973044718 sameAs 2973044718 @default.
• W2973044718 citedByCount "0" @default.
• W2973044718 crossrefType "journal-article" @default.
• W2973044718 hasAuthorship W2973044718A5017951736 @default.
• W2973044718 hasAuthorship W2973044718A5051744400 @default.
• W2973044718 hasAuthorship W2973044718A5080071712 @default.
• W2973044718 hasBestOaLocation W29730447181 @default.
• W2973044718 hasConcept C126322002 @default.
• W2973044718 hasConcept C126838900 @default.
• W2973044718 hasConcept C143998085 @default.
• W2973044718 hasConcept C144301174 @default.
• W2973044718 hasConcept C146357865 @default.
• W2973044718 hasConcept C151730666 @default.
• W2973044718 hasConcept C2776694085 @default.
• W2973044718 hasConcept C2777819096 @default.
• W2973044718 hasConcept C2780596822 @default.
• W2973044718 hasConcept C38180746 @default.
• W2973044718 hasConcept C509974204 @default.
• W2973044718 hasConcept C71924100 @default.
• W2973044718 hasConcept C86803240 @default.
• W2973044718 hasConceptScore W2973044718C126322002 @default.
• W2973044718 hasConceptScore W2973044718C126838900 @default.
• W2973044718 hasConceptScore W2973044718C143998085 @default.
• W2973044718 hasConceptScore W2973044718C144301174 @default.
• W2973044718 hasConceptScore W2973044718C146357865 @default.
• W2973044718 hasConceptScore W2973044718C151730666 @default.
• W2973044718 hasConceptScore W2973044718C2776694085 @default.
• W2973044718 hasConceptScore W2973044718C2777819096 @default.
• W2973044718 hasConceptScore W2973044718C2780596822 @default.
• W2973044718 hasConceptScore W2973044718C38180746 @default.
• W2973044718 hasConceptScore W2973044718C509974204 @default.
• W2973044718 hasConceptScore W2973044718C71924100 @default.
• W2973044718 hasConceptScore W2973044718C86803240 @default.
• W2973044718 hasIssue "1" @default.
• W2973044718 hasLocation W29730447181 @default.
• W2973044718 hasOpenAccess W2973044718 @default.
• W2973044718 hasPrimaryLocation W29730447181 @default.
• W2973044718 hasRelatedWork W2014435840 @default.
• W2973044718 hasRelatedWork W2155895993 @default.
• W2973044718 hasRelatedWork W2355670240 @default.
• W2973044718 hasRelatedWork W2362144381 @default.
• W2973044718 hasRelatedWork W2369232524 @default.
• W2973044718 hasRelatedWork W2376593068 @default.
• W2973044718 hasRelatedWork W2409999721 @default.
• W2973044718 hasRelatedWork W2412814609 @default.
• W2973044718 hasRelatedWork W2415260940 @default.
• W2973044718 hasRelatedWork W4291189777 @default.
• W2973044718 hasVolume "105" @default.
• W2973044718 isParatext "false" @default.
• W2973044718 isRetracted "false" @default.
• W2973044718 magId "2973044718" @default.
• W2973044718 workType "article" @default.